This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

ROBERT G. SIEKERT, M.D.

Arch Neurol. 1963;8(1):56-63.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Among the enzymes normally found in the body are the transaminases which catalyze the interconversion of an amino acid with a keto acid. The two most widely studied transaminases are glutamic oxaloacetic transminase and glutamic pyruvic transaminase, the former being the subject of the current study. Since skeletal muscle contains a high concentration of glutamic oxaloacetic transaminase, the present investigation, and extension of previous work with Fleisher, was carried out to ascertain whether the serum levels of this enzyme are altered in patients with muscular dystrophy.

Historical Review

Cohen studied these enzymes and, with Hekhuis, noted their wide distribution in the body. Another tissue enzyme, aldolase, was soon discovered by Warburg and Christian who found it to be elevated in the serum of rats with tumors. Sibley and Lehninger, in a survey of a large number of patients with various diseases, found that aldolase did not constitute a good test for cancer . . . [Full Text PDF of this Article]

Author Affiliations
ROCHESTER, MINN.

Footnotes
Submitted for publication June 11, 1962.

Section of Neurology, Mayo Clinic and Mayo Foundation.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?